New hair lotion could boost hair growth in balding men

NCT ID NCT04594018

Disease control Sponsor: EMS Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 3 trial tests a new hair lotion called Finlândia for male pattern baldness. About 190 men aged 18-60 with moderate hair loss will use the lotion or a standard treatment for 6 months. The main goal is to see if it increases hair density on the scalp.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: Finlândia hair lotion (combination product)
What this could lead to: If it works, this could offer a new topical treatment option for male pattern baldness, potentially improving hair density.
What could go wrong: This is a Phase 3 trial, but results may not show a significant benefit over existing treatments. Side effects are possible, and the study only includes men with specific baldness grades.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 190 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2023

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the informed consent forms; * Men aged 18 years or over and less than or equal to 60 years with a diagnosis of Androgenetic Alopecia grades IIIv to IV in the modified Norwood-Hamilton classification, who have been using minoxidil 5% for at least 3 months and willing to maintain the same style, approximate length and hair color throughout the test. Exclusion Criteria: * Known hypersensitivity to the formula components used during the clinical trial; * History of alcohol and/or substance abuse within 2 years; * Participants with other concomitant dermatological diseases on the scalp, except for mild seborrhoea dermatitis; * Participants with a history of surgical treatment for hair loss or shaved scalp; * Participants who used shampoo or topical solution containing ketoconazole, tar, selenium, threonine or steroids in the last 2 weeks; * Participants who used 5α reductase inhibitors, such as finasteride and dutasteride, in the last 12 months; * Participants using testosterone replacement therapy (TRT) or using testosterone-containing gel; * Participants who used micro-infusion of medications on the skin (MMP), microneedling or intradermotherapy on the scalp in the last 3 months; * Participants who have undergone radiation treatment for the scalp or chemotherapy in the past year; * Participants with diseases that can affect hair growth; * Participants with a current medical history of cancer and / or cancer treatment in the last 5 years;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Androgenetic alopecia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Androgenetic alopecia

How to take part

Only the study team decides who joins. These are the ways to reach them.

The places running it

1 site. The list below names each one and where it is.
The official record

ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

Open the record ↗
A doctor treating you

A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

New hair lotion could boost hair growth in balding men

What the study statuses mean